A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumours.
Lowis S, Lewis I, Elsworth A, Weston C, Doz F, Vassal G, Bellott R, Robert J, Pein F, Ablett S, Pinkerton R, Frappaz D; United Kingdom Children's Cancer Study Group (UKCCSG) New Agents; Société Française d'Oncologie Pédiatrique (SFOP) Pharmacology Group.
Lowis S, et al. Among authors: pinkerton r.
Br J Cancer. 2006 Sep 4;95(5):571-80. doi: 10.1038/sj.bjc.6603288. Epub 2006 Aug 1.
Br J Cancer. 2006.
PMID: 16880787
Free PMC article.
Clinical Trial.